| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Discovery Biology, XenoPort, Inc., Santa Clara, California 95051
Address all correspondence and requests for reprints to: Dr. Lori Roberts, Discovery Biology, XenoPort, Inc., 3410 Central Expressway, Santa Clara, California 95051. E-mail: Lori.Roberts{at}XenoPort.com.
Thyroid hormones require transport across cell membranes to carry out their biological functions. The importance of transport for thyroid hormone signaling was highlighted by the discovery that inactivating mutations in the human monocarboxylate transporter-8 (MCT8) (SLC16A2) cause severe psychomotor retardation due to thyroid hormone deficiency in the central nervous system. It has been reported that Mct8 expression in the mouse brain is restricted to neurons, leading to the model that organic ion transporter polypeptide-14 (OATP14, also known as OATP1C1/SLCO1C1) is the primary thyroid hormone transporter at the blood-brain barrier, whereas MCT8 mediates thyroid hormone uptake into neurons. In contrast to these reports, we report here that in addition to neuronal expression, MCT8 mRNA and protein are expressed in cerebral microvessels in human, mouse, and rat. In addition, OATP14 mRNA and protein are strongly enriched in mouse and rat cerebral microvessels but not in human microvessels. In rat, Mct8 and Oatp14 proteins localize to both the luminal and abluminal microvessel membranes. In human and rodent choroid plexus epithelial cells, MCT8 is concentrated on the epithelial cell apical surface and OATP14 localizes primarily to the basal-lateral surface. Mct8 and Oatp14 expression was also observed in mouse and rat tanycytes, which are thought to form a barrier between hypothalamic blood vessels and brain. These results raise the possibility that reduced thyroid hormone transport across the blood-brain barrier contributes to the neurological deficits observed in affected patients with MCT8 mutations. The high microvessel expression of OATP14 in rodent compared with human brain may contribute to the relatively mild phenotype observed in Mct8-null mice, in contrast to humans lacking functional MCT8.
This article has been cited by other articles:
 |
|
 |
|
  C. Di Cosmo, X.-H. Liao, A. M. Dumitrescu, R. E. Weiss, and S. Refetoff A Thyroid Hormone Analog with Reduced Dependence on the Monocarboxylate Transporter 8 for Tissue Transport Endocrinology, September 1, 2009; 150(9): 4450 - 4458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mebis, D. Paletta, Y. Debaveye, B. Ellger, L. Langouche, A. D'Hoore, V. M Darras, T. J Visser, and G. Van den Berghe Expression of thyroid hormone transporters during critical illness Eur. J. Endocrinol., August 1, 2009; 161(2): 243 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Wirth, S. Roth, C. Blechschmidt, S. M. Holter, L. Becker, I. Racz, A. Zimmer, T. Klopstock, V. Gailus-Durner, H. Fuchs, et al. Neuronal 3',3,5-Triiodothyronine (T3) Uptake and Behavioral Phenotype of Mice Deficient in Mct8, the Neuronal T3 Transporter Mutated in Allan-Herndon-Dudley Syndrome J. Neurosci., July 29, 2009; 29(30): 9439 - 9449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ceballos, M. M. Belinchon, E. Sanchez-Mendoza, C. Grijota-Martinez, A. M. Dumitrescu, S. Refetoff, B. Morte, and J. Bernal Importance of Monocarboxylate Transporter 8 for the Blood-Brain Barrier-Dependent Availability of 3,5,3'-Triiodo-L-Thyronine Endocrinology, May 1, 2009; 150(5): 2491 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Heuer and T. J. Visser Pathophysiological Importance of Thyroid Hormone Transporters Endocrinology, March 1, 2009; 150(3): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
